Activaero was a therapeutic area specialist developing cutting-edge solutions for patients suffering from severe respiratory diseases, including Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF), Idiopathic Pulmonary Fibrosis (IPF) and other severe lung diseases. Activaero´s clinically proven treatment approach ensures highly efficient and safe local drug deposition in the lungs to fight severe respiratory diseases with dramatically better therapy outcomes. In 2014 Activaero was aquired by Vectura plc.
The unique combination of effective but underutilized drugs with Activaero’s superior FAVORITE approach is fuelling a pipeline of highly differentiated respiratory therapeutic solutions. Activaero has a comprehensive proprietary clinical development program under way and its smart and cost efficient treatment strategies are externally validated by partnerships with leading pharma and biotech companies.
Company Details
- Founded
- -
- Phone
- 4964536481822
- in****@****aero.de
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- activaero.de
Activaero Gmbh Questions
Activaero Gmbh's helpline number is 4964536481822
Activaero Gmbh's website is activaero.de
Activaero Gmbh's LinkedIn profile is https://de.linkedin.com/company/activaero-gmbh
Activaero Gmbh's industry is
Pharmaceutical Manufacturing
Activaero Gmbh's top competitors are
Resyca,
Vectura Group,
Ambu Gmbh - Deutschland,
Miraculix-Lab,
Olfactive Biosolutions,
Activoris Group,
Gs Bio-Inhalation Gmbh,
Qrumpharma Inc.,
Gates Institute,
Octapharma Germany.
Activaero Gmbh's support email address is info@activaero.de
Activaero Gmbh's categories are Pharmaceutical Manufacturing
Activaero Gmbh's founding year is 1998
